Tag Archives: CYTR

Top 5 Warren Buffett Stocks To Buy Right Now

Leave a reply

You have an investing advantage over Warren Buffett. No, seriously, you really do.

Buffett has admitted that he regrets not buying Google parent Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) and Amazon.com years ago. And he’s only been a big buyer of Apple stock in the past few years. Apple gained more than 2,000% in the 10 years before Buffett jumped aboard.

The reality is that Buffett doesn’t invest in what he doesn’t understand. That means he can miss out on some of the hottest trends — at least for a while. And therein lies your advantage: gaining an understanding of trends relatively early on and buying the best stocks to profit from those trends. Here are three hot trends that Buffett is missing out on, along with investing ideas for each one.

Image source: Getty Images.

Top 5 Warren Buffett Stocks To Buy Right Now: Permian Basin Royalty Trust(PBT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Primalbase Token (CURRENCY:PBT) traded down 7.8% against the US dollar during the 24 hour period ending at 12:00 PM ET on May 22nd. Primalbase Token has a total market capitalization of $2.53 million and $838,489.00 worth of Primalbase Token was traded on exchanges in the last day. One Primalbase Token token can currently be bought for $2,024.98 or 0.24530700 BTC on popular cryptocurrency exchanges including Tidex and Waves Decentralized Exchange. During the last seven days, Primalbase Token has traded down 14.5% against the US dollar.

  • [By Joseph Griffin]

    Primalbase Token (CURRENCY:PBT) traded up 8.5% against the dollar during the twenty-four hour period ending at 17:00 PM E.T. on September 4th. Primalbase Token has a market capitalization of $5.13 million and $2,945.00 worth of Primalbase Token was traded on exchanges in the last 24 hours. One Primalbase Token token can now be bought for about $4,100.42 or 0.55692938 BTC on major cryptocurrency exchanges including Waves Decentralized Exchange and Tidex. Over the last seven days, Primalbase Token has traded up 6.6% against the dollar.

  • [By Joseph Griffin]

    Media stories about Permian Basin Royalty Trust (NYSE:PBT) have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Permian Basin Royalty Trust earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned media coverage about the oil and gas producer an impact score of 46.225040116545 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 5 Warren Buffett Stocks To Buy Right Now: Tetra Tech Inc.(TTEK)

Advisors’ Opinion:

  • [By Logan Wallace]

    Tetra Tech, Inc. (NASDAQ:TTEK) shares hit a new 52-week high on Friday . The company traded as high as $71.15 and last traded at $70.70, with a volume of 2488 shares. The stock had previously closed at $70.20.

  • [By Joseph Griffin]

    Thrivent Financial for Lutherans increased its position in shares of Tetra Tech, Inc. (NASDAQ:TTEK) by 6.4% during the 1st quarter, Holdings Channel reports. The firm owned 37,544 shares of the industrial products company’s stock after purchasing an additional 2,262 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Tetra Tech were worth $1,838,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Tetra Tech (TTEK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Tetra Tech (TTEK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Tetra Tech (TTEK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Warren Buffett Stocks To Buy Right Now: CytRx Corporation(CYTR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on CytRx (CYTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News coverage about CytRx (NASDAQ:CYTR) has trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CytRx earned a news sentiment score of 0.17 on Accern’s scale. Accern also gave media coverage about the biotechnology company an impact score of 46.6205108631258 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Logan Wallace]

    Oncobiologics (NASDAQ: ONS) and CytRx (NASDAQ:CYTR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Top 5 Warren Buffett Stocks To Buy Right Now: The Hanover Insurance Group, Inc.(THG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Goelzer Investment Management Inc. reduced its holdings in shares of The Hanover Insurance Group, Inc. (NYSE:THG) by 3.7% during the 1st quarter, HoldingsChannel reports. The fund owned 40,309 shares of the insurance provider’s stock after selling 1,563 shares during the period. Goelzer Investment Management Inc.’s holdings in The Hanover Insurance Group were worth $4,752,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Scout Investments Inc. acquired a new position in shares of The Hanover Insurance Group, Inc. (NYSE:THG) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 174,629 shares of the insurance provider’s stock, valued at approximately $20,587,000. Scout Investments Inc. owned about 0.41% of The Hanover Insurance Group at the end of the most recent quarter.

  • [By Shane Hupp]

    Hanover Insurance Group (NYSE:THG) was downgraded by equities researchers at Sandler O’Neill from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, The Fly reports.

  • [By Stephan Byrd]

    Hanover Insurance Group Inc (NYSE:THG) insider Mark Joseph Welzenbach sold 2,216 shares of the company’s stock in a transaction on Thursday, February 7th. The stock was sold at an average price of $115.24, for a total transaction of $255,371.84. Following the completion of the sale, the insider now owns 17,559 shares of the company’s stock, valued at approximately $2,023,499.16. The transaction was disclosed in a filing with the SEC, which is available through this link.

  • [By Max Byerly]

    ValuEngine upgraded shares of Hanover Insurance Group (NYSE:THG) from a hold rating to a buy rating in a research report sent to investors on Thursday.

Top 5 Warren Buffett Stocks To Buy Right Now: San Juan Basin Royalty Trust(SJT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media stories about San Juan Basin Royalty Trust (NYSE:SJT) have trended positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. San Juan Basin Royalty Trust earned a media sentiment score of 0.34 on Accern’s scale. Accern also gave news articles about the oil and gas producer an impact score of 48.2365151407757 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Hot Clean Energy Stocks To Invest In 2018

Leave a reply

If you’re looking to invest in renewable power stocks, you can always pick out pure plays that take advantage of the huge demand for clean energy — and with utility customers inking long-term power contracts as they switch from dirty carbon-based fuels, that might be a winning strategy. However, what if the growth story behind renewables doesn’t live up to today’s hype?

That uncertainty is why a diversified company like NextEra Energy, Inc. (NYSE:NEE), with utility and renewable power operations, might make more sense for conservative investors.

Focusing on renewables

There’s no question that a company like Brookfield Renewable Partners L.P. (NYSE:BEP) is a great direct play on renewable power. Roughly 80% of the company’s power is hydroelectric, with the rest made up largely of wind and solar. Moreover, it has exposure to Brazil (20% of generation) and Columbia (15%), in addition to the United States (60%). Much of the company’s growth has come from acquisitions, and long-term contracts back up the bulk of its revenues. It’s a perfectly fine renewable power investment.

Hot Clean Energy Stocks To Invest In 2018: CytRx Corporation(CYTR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Oncobiologics (NASDAQ: ONS) and CytRx (NASDAQ:CYTR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on CytRx (CYTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Clean Energy Stocks To Invest In 2018: Henry Schein, Inc.(HSIC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Henry Schein (HSIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Henry Schein (NASDAQ:HSIC)‘s stock had its “hold” rating reissued by investment analysts at Barclays in a report released on Wednesday. They presently have a $73.00 price objective on the stock. Barclays’ price objective would suggest a potential upside of 2.70% from the company’s previous close.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Henry Schein, Inc. (NASDAQ: HSIC) which rose over 6% to $73.68. The stocks 52-week range is $62.56 to $93.50. Volume was 3.3 million compared to the daily average volume of 1.9 million.

Hot Clean Energy Stocks To Invest In 2018: Flowserve Corporation(FLS)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Alphabet Inc. (Nasdaq: GOOGL), Microsoft Corp.(Nasdaq: MSFT), and Apple Inc. (Nasdaq: AAPL) received approval from the U.S. Transportation Department to begin pilot programs for drone delivery services. Missing from the list of approved companies was Amazon.com Inc.(Nasdaq: AMZN). The tech giant has long been an advocate for drone delivery, and its absence came as a surprise to the tech community. It will be a busy day for economic data announcements. Most important will be a report on inflation at 8:30 EDT. Strong price growth has picked up to start the year. This has many economists anticipating that the U.S. Federal Reserve will raise interest rates to stave off additional inflation. Meanwhile, the Bank of England announced that it will hold its benchmark interest rate at 0.5%. The country is still facing economic uncertainty over Brexit.
    Three Stocks to Watch Today: BKNG, SHLD, F
    A weak guidance report has shares of Booking Holdings Inc.(Nasdaq: BKNG) off 6% this morning. Although the travel site operator easily topped Wall Street earnings and revenue expectations, the firm once known as Priceline offered a weak 2018 outlook. That sent investors heading for the exits.
    Sears Holdings Corp. (Nasdaq: SHLD) stock popped more than 16% on Wednesday afternoon. The news came after the embattled retail company announced plans to partner with Amazon.comto sell tires. The plan is part of the company’s broader turnaround strategy to make the retail firm profitable again. Ford Motor Co.(NYSE: F) made a stunning announcement on Wednesday. The company said that it will halt production of its F-Series pickup truck. But the move will only be temporary. A fire at a Michigan plant temporarily caused the automotive giant to run out of parts for the top-selling U.S. vehicle. The shutdown could last several weeks, although the company said it has enough parts inventory to last about 12 weeks. Look for additional earnings reports from Nvidia Corp.(Nasdaq: NVDA

  • [By Joseph Griffin]

    Press coverage about Flowserve (NYSE:FLS) has trended somewhat positive on Saturday, according to Accern. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Flowserve earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned media coverage about the industrial products company an impact score of 46.7836910204953 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Max Byerly]

    Flowserve (NYSE:FLS) – Stock analysts at Seaport Global Securities boosted their Q2 2018 EPS estimates for Flowserve in a research report issued on Monday, May 14th. Seaport Global Securities analyst W. Liptak now forecasts that the industrial products company will post earnings per share of $0.35 for the quarter, up from their previous forecast of $0.31. Seaport Global Securities also issued estimates for Flowserve’s Q3 2018 earnings at $0.48 EPS, Q4 2018 earnings at $0.55 EPS and FY2018 earnings at $1.64 EPS.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    NVIDIA Corporation (NASDAQ: NVDA) is estimated to post quarterly earnings at $1.45 per share on revenue of $2.89 billion.
    News Corporation (NASDAQ: NWSA) is projected to post quarterly earnings at $0.07 per share on revenue of $1.99 billion.
    Symantec Corporation (NASDAQ: SYMC) is estimated to post quarterly earnings at $0.39 per share on revenue of $1.19 billion.
    Pilgrim's Pride Corporation (NASDAQ: PPC) is projected to post quarterly earnings at $0.54 per share on revenue of $2.65 billion.
    Hawaiian Electric Industries, Inc. (NYSE: HE) is expected to post quarterly earnings at $0.38 per share on revenue of $556.81 million.
    Air Lease Corporation (NYSE: AL) is estimated to post quarterly earnings at $1.01 per share on revenue of $383.37 million.
    Flowserve Corporation (NYSE: FLS) is expected to post quarterly earnings at $0.27 per share on revenue of $880.89 million.
    Civitas Solutions, Inc. (NYSE: CIVI) is projected to post quarterly earnings at $0.12 per share on revenue of $396.25 million.
    The Trade Desk, Inc. (NASDAQ: TTD) is estimated to post quarterly earnings at $0.1 per share on revenue of $73.23 million.
    Amdocs Limited (NYSE: DOX) is projected to post quarterly earnings at $0.95 per share on revenue of $980.50 million.
    Yelp Inc. (NYSE: YELP) is estimated to post quarterly loss at $0.04 per share on revenue of $220.14 million.
    Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) is expected to post quarterly earnings at $0.43 per share on revenue of $210.01 million.
    TiVo Corporation (NASDAQ: TIVO) is projected to post quarterly earnings at $0.37 per share on revenue of $198.62 million.
    Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) is expected to post quarterly earnings at $0.17 per share on revenue of $153.87 million.
    Uniti Group Inc. (NASDAQ: UNIT) is estimated to post quarterly earnings at $0.01 per share on revenue of $247.16 million.
    Jagged Peak En

Hot Clean Energy Stocks To Invest In 2018: Maxwell Technologies, Inc.(MXWL)

Advisors’ Opinion:

  • [By Logan Wallace]

    News articles about Maxwell Technologies (NASDAQ:MXWL) have been trending somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Maxwell Technologies earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave press coverage about the electronics maker an impact score of 46.3845155482228 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Shares of Maxwell Technologies Inc. (NASDAQ:MXWL) have earned an average recommendation of “Buy” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $7.25.

  • [By Ethan Ryder]

    HRG Group (NYSE: HRG) and Maxwell Technologies (NASDAQ:MXWL) are both consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, valuation and dividends.

Hot Clean Energy Stocks To Invest In 2018: SurModics Inc.(SRDX)

Advisors’ Opinion:

  • [By Max Byerly]

    Lombard Medical Technologies (OTCMKTS: EVARF) and SurModics (NASDAQ:SRDX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, institutional ownership, dividends, valuation and earnings.

  • [By Ethan Ryder]

    Shares of SurModics, Inc. (NASDAQ:SRDX) hit a new 52-week high and low during trading on Tuesday . The stock traded as low as $47.30 and last traded at $47.20, with a volume of 902 shares. The stock had previously closed at $46.50.

Top 10 Stocks To Own For 2018

Leave a reply

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-1060141868&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1060141868/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Shutterstock

With just over a week to go until&a;nbsp;Tax Day (it&s;s&a;nbsp;&l;a href=&q;https://www.forbes.com/sites/kellyphillipserb/2018/01/04/irs-announces-2018-filing-season-opens-january-29-reminds-taxpayers-about-delayed-refunds/#587ab89410da&q;&g;April 17 this year&l;/a&g;), you have a few options available if you still haven&s;t yet filed your tax return. You can:

&l;/p&g;&l;ul&g;&l;li&g;Call and hope to get a last-minute tax appointment;&l;/li&g;

&l;li&g;Download tax prep software and figure you&s;ll squeeze the time to file while binge-watching &l;em&g;Stranger Things&l;/em&g;;&l;/li&g;

&l;li&g;Rock back and forth quietly under your desk while promising to be more prepared next year; or&l;/li&g;

&l;li&g;You can join the nearly 10 million taxpayers who are expected to file for an extension.&l;/li&g;

Top 10 Stocks To Own For 2018: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Horizon Investments]

    For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 – the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company’s management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

Top 10 Stocks To Own For 2018: PAR Technology Corporation(PAR)

Advisors’ Opinion:

  • [By Lisa Levin]

    PAR Technology Corporation (NYSE: PAR) shares were also up, gaining 15 percent to $6.59. Par Technology reported Q4 adjusted earnings of $0.13 per share on revenue of $56.8 million.

  • [By Lisa Levin]

    On Tuesday, technology shares gained by 1.61 percent. Meanwhile, top gainers in the sector included Himax Technologies, Inc. (ADR) (NASDAQ: HIMX), up 13 percent, and PAR Technology Corporation (NYSE: PAR), up 9 percent.

Top 10 Stocks To Own For 2018: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Gilead Sciences have dipped 0.1% to $68.97 at 1:05 p.m. today, while the iShares Nasdaq Biotechnology ETF (IBB) has risen 0.4% to $296.51.

  • [By Kumar Abhishek]

    Shares of Foster City, California-based, biotech major, Gilead Sciences, Inc(NASDAQ:GILD) have been on a consistent decline in the last one year or so. After being one of the best performers in the biotech space since 2012, Gilead stock has lost more than 12% in last one year, while theNasdaq Composite (INDX:COMPX) has gained by more than 24% in the same period, resulting in a massive underperformance. Gilead stock has underperformedeven the iShares NASDAQ Biotech Index ETF (NASDAQ:IBB) which has returned more than 14% during the same period. Gilead stock has been making lower lows and lower highs going into the earnings, indicating a clear downtrend in the stock. The stock hit its 52 week low of $69.78 recently on January 24th, just days ahead of its Q4 earnings result. Gilead Sciences, Incis scheduled to report its Q4 2016 and FY 2016 earnings on 7th of February, after the market close.

  • [By Ben Levisohn]

    Biotech stocks are having a great day today–iShares Nasdaq Biotechnology ETF (IBB) has climbed 2.5% to $276.92–leading some to suggest that 2017 could be better for investors than 2016 was. Not Baird’s Brian Skorney and Michael Ulz, who “don’t think 2017 will be worse than 2016″ but “aren’t quite sure it will be much better.” They explain why:

    Agence France-Presse/Getty Images

    Short story is, growth products are slowing and large net price increases are appearing increasingly unsustainable, even if the government doesn’t intervene. The innovation cycle appears to be in a waning period and, so far, large-caps with boatloads of cash seem to be hesitant to act. 2017 should have some excitement. We may finally see a successful registrational study in Alzheimer’s disease (Axovant Sciences’ (AXON) intepirdine or Merck’s (MRK) verubecestat), CAR T will finally get to plead its case, and we may find out once and for all if those ‘transformational’ PCSK9s are just that…

    A steadily building pharma cash war chest is a big offsetting tailwind. As Princess Leia would say, “Help me M&A, you’re my only hope.”

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

Top 10 Stocks To Own For 2018: CytRx Corporation(CYTR)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.

    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Stocks To Own For 2018: Castlight Health, inc.(CSLT)

Advisors’ Opinion:

  • [By Todd Campbell]

    Castlight Health (NYSE:CSLT)share price climbed 13.2% Wednesday after an SEC filing revealed that Maverick Capital had significantly boosted its stake in the company to 10.6%.

Top 10 Stocks To Own For 2018: Western Asset Mortgage Capital Corporation(WMC)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine lowered shares of Western Asset Mortgage Capit (NYSE:WMC) from a buy rating to a hold rating in a research report report published on Wednesday.

Top 10 Stocks To Own For 2018: SPDR Wells Fargo Preferred Stock ETF (PSK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI holds five other SSgA fixed income ETFs, including the SPDR Wells Fargo Preferred Stock ETF (NYSE: PSK). PSK is DWFI's largest holding at a weight of 25.2 percent. DWFI's second-largest holding is an allocation of almost 25 percent to the SPDR Nuveen Barclays Municipal Bond ETF (NYSE: TFI).

Top 10 Stocks To Own For 2018: comScore Inc.(SCOR)

Advisors’ Opinion:

  • [By Paul Ausick]

    comScore Inc. (NASDAQ: SCOR) dropped more than 10% on Tuesday to record a new 52-week low of $20.81. The stock closed at $23.22 on Monday. Volume was about 9 times the daily average of around 470,000 shares. The company’s stock will be de-listed from Nasdaq effective February 8 unless the company receives a stay from the exchange.

Top 10 Stocks To Own For 2018: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Caladrius Biosciences Inc (NASDAQ: CLBS) shares shot up 14 percent to $5.83 after the company posted upbeat Q4 results.

    Shares of Norsat International Inc (USA) (NYSE: NSAT) got a boost, shooting up 22 percent to $9.85 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Caladrius Biosciences Inc. (NASDAQ: CLBS) watchedits shares soar on Thursday after the company announced a private placement offering. In terms of the specifics, the company entered into securities purchase agreements with several accredited investors for the sale of 4,449,153 shares of its common stock in private placements of $21 million.

Top 10 Stocks To Own For 2018: News Corporation(NWS)

Advisors’ Opinion:

  • [By Monica Gerson]

    News Corp (NASDAQ: NWS) reported a profit of $506 million, or $0.87 per share for the year ended June 30, versus a year-ago loss of $2.08 billion, or $3.58 per share. Its revenue rose 2.7% to $8.89 billion. However, analysts were expecting earnings of $0.57 per share on revenue of $8.96 billion. News Corp shares fell 1.28% to close at $16.91 on Friday.

  • [By Joseph Griffin]

    New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Top 5 Low Price Stocks To Buy Right Now

Leave a reply

Source: ThinkstockUntil about 2008 or so, discussion about the future price of crude oil was directed by the concept of peak oil. That is, when does the world reach peak production, after which the price of crude will skyrocket. In less than a decade, the discussion is now focused on the concept of “peak demand,” the point at which global demand for crude begins to decline.

The recent Oil & Money conference in London sharpened the focus on peak demand. Saudi Arabia’s minister of energy and industry, Khalid Al-Falih, told conference attendees that cutbacks in capital spending on exploration, forced on the industry by low prices for the past twoyears, could mean that shortfalls in supply are coming.

Exxon Mobil Corp. (NYSE: XOM) CEO Rex Tillerson disagreed:

Top 5 Low Price Stocks To Buy Right Now: Prima BioMed Ltd(PBMD)

Advisors’ Opinion:

  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) shares dipped 38.59% to touch a new 52-week low of $1.44 after the company reported top-line analysis of CVac Phase 2 trial.

  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) dropped 38.17% to $1.45 after the company reported top-line analysis of CVac Phase 2 trial.

    Tower Group International (NASDAQ: TWGP) plummeted 24.31% to $10.49. Tower Group announced its plans to release its Q2 results during the week of October 7, 2013. FBR Capital downgraded the stock from Outperform to Market Perform.

Top 5 Low Price Stocks To Buy Right Now: IF Bancorp, Inc.(IROQ)

Advisors’ Opinion:

  • [By Max Byerly]

    News stories about IF Bancorp (NASDAQ:IROQ) have been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. IF Bancorp earned a news sentiment score of 0.16 on Accern’s scale. Accern also gave news coverage about the savings and loans company an impact score of 47.5310825195986 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 5 Low Price Stocks To Buy Right Now: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

Top 5 Low Price Stocks To Buy Right Now: Briggs & Stratton Corporation(BGG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) fell 23.3 percent to $9.87 in pre-market trading after declining 13.45 percent on Wednesday.
    SunCoke Energy Partners, L.P. (NYSE: SXCP) fell 12.8 percent to $16.00 in pre-market trading after reporting Q1 results.
    Briggs & Stratton Corporation (NYSE: BGG) fell 11 percent to $17.55 in pre-market trading after the company posted mixed Q3 results and lowered its FY18 guidance.
    New Gold Inc. (NYSE: NGD) fell 8.4 percent to $2.30 in pre-market trading following downbeat Q1 results.
    Quality Care Properties, Inc. (NYSE: QCP) fell 8.2 percent to $20.85 in pre-market trading. Welltower announced plans to acquire QCP for $20.75 per share in cash.
    China Customer Relations Centers Inc. (NASDAQ: CCRC) shares fell 7.5 percent to $17.25 in pre-market trading after climbing 18.73 percent on Wednesday.
    Nokia Corporation (NYSE: NOK) shares fell 5.7 percent to $5.58 in pre-market trading after reporting Q1 results.
    eBay Inc. (NASDAQ: EBAY) fell 5.6 percent to $38.66 in pre-market trading following Q1 results.
    Southw

  • [By ]

    For his “Executive Decision” segment, Cramer spoke with Todd Teske, chairman, president and CEO of Briggs & Stratton (BGG) , the small-engine maker that posted a penny-a-share earnings beat on Wednesday, but saw shares fall 11% on lighter-than-expected revenues and a cut in the company’s full-year guidance.

Top 5 Low Price Stocks To Buy Right Now: CytRx Corporation(CYTR)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.

    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Medical Stocks To Own Right Now

Leave a reply

5 Lessons From the Life of David Noble

DOL Fiduciary Rule Hurts Now, Annuity Community Says

5 Lessons From the Life of David Noble

(Bloomberg) — The Trump White House and congressional Republicans were at odds Thursday over whether to try for another vote on changing the Affordable Care Act next week, indicating that neither side had a clear strategy for moving on one of the president’s central campaign promises.

A White House aide said President Donald Trump’s administration expects the House to vote soon after lawmakers return from recess on Tuesday, and draft language could be circulated as soon as Thursday night. Success would give the president a legislative victory to boast about before his 100th day in office April 29.

Copyright 2017 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

One Republican said he thinks both about the effects of regulations and his family’s medical history.

Top Medical Stocks To Own Right Now: Richmont Mines, Inc.(RIC)

Advisors’ Opinion:

  • [By Sally Jones]

    Richmont Mines Inc. (RIC)

    Down 70% over 12 months, Richmont Mines Inc. has a market cap of $56.23 billion, and trades with a P/B of 0.60.

Top Medical Stocks To Own Right Now: CytRx Corporation(CYTR)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.

    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Medical Stocks To Own Right Now: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Aerohive Networks Inc (NYSE: HIVE) were down 33 percent to $3.10. Aerohive Networks reported a Q2 loss of $3.9 million on revenue of $42.3 million, and disclosed that it has extended its $10 million buyback plan.

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.16 per share on revenue of $17.34 billion before the opening bell. Citigroup shares rose 0.47 percent to $48.70 in after-hours trading.
    HP Inc (NYSE: HPQ) disclosed that it would be implementing a restructuring plan that would likely result in the firing of 3,000 to 4,000 employees, annual savings of $200 million to $300 million, and a charge of $350 million to $500 million. Management also announced a 7 percent surge in the stock’s dividend and an additional $3 million share repurchase program. The company issued its outlook for fiscal 2017, guiding for EPS of $1.55 to $1.65, mostly below the Street’s consensus of $1.64. HP shares fell 1.32 percent to $14.95 in the after-hours trading session.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.39 per share on revenue of $23.99 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.37 perecent to $67.99 in after-hours trading.
    Aerohive Networks Inc (NYSE: HIVE) reported weak preliminary results for its third quarter. The company said it expects a net loss of $(0.06) to $(0.07) per share, versus consensus at $(0.04) per share. Revenue guidance of $40 million also fell short of expectations for almost $48 million. Aerohive shares dropped 18.29 percent to $4.60 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.